article thumbnail

Time to look Beyond Compulsory Licenses? A Glimpse at the Ribociclib Case

SpicyIP

Image from here Recently, the Print reported that Novartis and Eli Lilly have voiced their opposition to the idea of compulsory licensing (“ CL ”) for breast cancer medications, Ribociclib and Abemaciclib. million breast cancer cases are expected globally by 2050. It also says that no licenses were given out. of GDP in FY23.

article thumbnail

Sunday Surprises

The IPKat

31 May 2022 | 16:00 – 17:00 (GMT+2) | 4IP Council | Webinar: “ Green-tech, patents, standards: how to achieve global climate neutrality by 2050 ” (online) The 4IP Council is organising a one-hour webinar on the impact of IP on global climate neutrality. It's getting hot out there! Picture by idea-saras.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

COP26 – Trends in Latin America

Herbert Smith Freehills

As part of its Decarbonization Plan, Costa Rica is committed to reaching zero carbon emissions by 2050. Bill 3729/2004 was also approved by Congress, which creates more flexible and simpler processes for environmental licensing within Brazil. .

article thumbnail

COP26 – Trends in Latin America

Herbert Smith Freehills

As part of its Decarbonization Plan, Costa Rica is committed to reaching zero carbon emissions by 2050. Bill 3729/2004 was also approved by Congress, which creates more flexible and simpler processes for environmental licensing within Brazil. .

article thumbnail

COP27 and the UK energy sector – between a rock and a hard place

Herbert Smith Freehills

In 2021 the UK enshrined in law a pledge to reduce emissions by 78% by 2035 (compared to 1990 levels), with an overarching commitment to reach net zero by 2050. UK CLIMATE COMMITMENTS. The UK Government has stated that its strategy for net zero is to "lead the world in ending our contribution to climate change".